CoChat

Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management

Open access
Ilyas, Sumera I., Eaton, John E., Gores, Gregory J. · 2015 · Clinical Gastroenterology and Hepatology
Cited by 122

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Primary sclerosing cholangitis (PSC) is a pre-malignant biliary tract disease that confers a significant risk for the development of cholangiocarcinoma (CCA). The chronic biliary tract inflammation of PSC promotes pro-oncogenic processes such as cellular proliferation, induction of DNA damage, alterations of the extracellular matrix and cholestasis. The diagnosis of malignancy in PSC can be challenging as inflammation-related changes in PSC may produce dominant biliary tract strictures mimicking CCA. Biomarkers such as detection of methylated genes in biliary specimens represent non-invasive techniques which may discriminate malignant biliary ductal changes from PSC strictures. However, conventional cytology and advanced cytologic techniques such as fluorescence in situ hybridization (FISH) for polysomy remain the practice standard for diagnosing CCA in PSC. Curative treatment options of malignancy arising in PSC are limited. For a subset of patients selected using stringent criteria, liver transplantation following neoadjuvant chemoradiation is a potential curative therapy. However, most patients have advanced malignancy at the time of diagnosis. Advances directed at identifying high risk patients, early cancer detection, and development of chemopreventive strategies will be essential to better manage the cancer risk in this pre-malignant disease. A better understanding of dysplasia definition and especially its natural history is also needed in this disease. Herein, we review recent developments in our understanding of the risk factors, pathogenic mechanisms of PSC associated with CCA, as well as advances in early detection and therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cgh.2015.05.035

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 122

Metadata

Authors
Ilyas, S. I., Eaton, J. E., & Gores, G. J.
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2015-11
Volume
13
Issue
12
Pages
2152-2165
ISSN
1542-3565 (ISSN-L)
OpenAlex
W1841980817
Cited by
122
References
22
FWCI
7.33
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management. https://app.cochat.ai/papers/10.1016/j.cgh.2015.05.035
The paper
Ilyas, S. I., Eaton, J. E., & Gores, G. J. (2015). Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2015.05.035

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.